Periprosthetic Joint Infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with complete medical records and diagnosed as PJI according to the MSIS standard; 2. Patients voluntarily participated in this study, were physically and mentally capable of tolerating the treatment process and various tests of this study, and agreed to use molecular diagnostic methods to assist in diagnosis. They have signed the informed consent form and have passed the review of the Hospital Ethics Committee of the First Affiliated Hospital of Fujian Medical University.
Exclusion criteria
Exclusion criteria: 1. Those who had chronic inflammation in other parts before the surgery; 2. Patients with complex conditions requiring combined diagnosis of multiple pathogens; 3. Patients who lost follow-up; 4. Those with an expected lifespan of less than half a year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Infection clearance rate in PJI patients; | — |
Secondary
| Measure | Time frame |
|---|---|
| The rate of targeted use of antibiotics;The incidence rate of antibiotic complications;Adverse events related to PJI;The detection rate of pathogenic bacteria and the spectrum of pathogenic microorganisms;The diagnostic efficacy of traditional microbial cultivation and pathogen-specific diagnosis system in PJI;Postoperative joint function score; | — |
Countries
China
Contacts
First Affiliated Hospital of Fujian Medical University